切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - ADAMs - TAK1 - adrenergic receptor - Proteasome

20件产品中的 1-10

页面
每页
清除全部
  1. VR23
    B6026 VR23
    Target: Proteasome
    Summary: 蛋白酶抑制剂
      ≥45.55 mg/mL
      insoluble in H2O
  2. (5Z)-7-Oxozeaenol
    B7443 (5Z)-7-Oxozeaenol
     1 Citation
    Target: TAK1
    Summary: TAK1促分裂原活化蛋白激酶激酶激酶(MAPKKK)抑制剂
      <9.06 mg/mL
      insoluble in ethanol
  3. Epinephrine Bitartrate
    B1358 Epinephrine Bitartrate
    中文名: 酒石酸肾上腺素
    Target: adrenergic receptor
    Summary: 肾上腺素能受体激动剂
      ≥16.66 mg/mL
      ≥22.9 mg/mL
  4. Latrepirdine
    B1572 Latrepirdine
    Target: Voltage-gated Calcium Channels (CaV)|NMDA receptor|adrenergic receptor|Histamine receptors|GluR|5-HT receptor|dopamine receptors|AMPA receptor
    Summary: 脑细胞死亡抑制剂
      ≥19.62 mg/mL
      insoluble in H2O
  5. PYR-41
    B1492 PYR-41
     2 Citation
    Target: Proteasome
    Summary: 泛素活化酶(E1)抑制剂
      ≥18.55 mg/mL
      insoluble in H2O
  6. GI 254023X
    A4436 GI 254023X
     2 Citation
    Target: ADAMs
    Summary: ADAM10金属蛋白酶抑制剂
      ≥42.6 mg/mL
      insoluble in H2O
  7. Quetiapine
    A3744 Quetiapine
    中文名: 喹硫平
    Target: AChR|adrenergic receptor|5-HT receptor|Dopamine receptor|Histamine receptor
    Summary: 多巴胺受体拮抗剂
      ≥19.18 mg/mL
      insoluble in H2O
  8. Dronedarone
    A3374 Dronedarone
    中文名: 决奈达隆
    Target: Cytochrome P450 (CYP450)|sodium channel|adrenergic receptor|potassium channel|calcium channel
    Summary: CYP3A4和2D6抑制剂
      ≥27.84 mg/mL
      insoluble in H2O
  9. AM 114
    A8163 AM 114
     2 Citation
    Target: Proteasome
    Summary: 20S蛋白酶体抑制剂
      ≥16.65 mg/mL
      insoluble in H2O
  10. Carfilzomib (PR-171)
    A1933 Carfilzomib (PR-171)
     10 Citation
    中文名: 卡非佐米
    Target: Proteasome
    Summary: 蛋白酶体抑制剂
      ≥35.99 mg/mL
      insoluble in H2O

20件产品中的 1-10

页面
每页